338 related articles for article (PubMed ID: 35752436)
1. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
Papaioannou AI; Fouka E; Tzanakis N; Antoniou K; Samitas K; Zervas E; Kostikas K; Bartziokas K; Porpodis K; Papakosta D; Tzouvelekis A; Gerogianni I; Kotsiou O; Makris M; Rovina N; Vlachou G; Markatos M; Vittorakis S; Katsoulis K; Papanikolaou I; Afthinos A; Katsaounou P; Steiropoulos P; Latsios D; Dimakou K; Koukidou S; Hillas G; Tryfon S; Kallieri M; Georgopoulou A; Avarlis P; Bakakos P; Markopoulou K; Gaki E; Paspala A; Kyriakaki Z; Gourgoulianis KI; Papiris S; Loukides S
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2588-2595. PubMed ID: 35752436
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
Adir Y; Humbert M; Saliba W
J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
[TBL] [Abstract][Full Text] [Related]
3. Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective study.
Manti S; Giallongo A; Pecora G; Parisi GF; Papale M; Mulè E; Aloisio D; Rotolo N; Leonardi S
Pediatr Pulmonol; 2023 Apr; 58(4):1085-1091. PubMed ID: 36593591
[TBL] [Abstract][Full Text] [Related]
4. Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.
Patella V; Pelaia C; Zunno R; Pelaia G
Respir Med; 2022; 200():106916. PubMed ID: 35809428
[TBL] [Abstract][Full Text] [Related]
5. The course of COVID-19 in patients with severe asthma receiving biological treatment.
Tuncay G; Cakmak ME; Can Bostan O; Kaya SB; Damadoglu E; Karakaya G; Kalyoncu AF
J Asthma; 2022 Nov; 59(11):2174-2180. PubMed ID: 34669544
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
[TBL] [Abstract][Full Text] [Related]
7. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
Timberlake DT; Strothman K; Grayson MH
Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
[TBL] [Abstract][Full Text] [Related]
8. Asthma and COVID-19: an update.
Adir Y; Saliba W; Beurnier A; Humbert M
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
[TBL] [Abstract][Full Text] [Related]
9. Safety of biological therapy in children and adolescents with severe asthma during the COVID-19 pandemic: a case series.
Votto M; Santi V; Bajeli M; De Filippo M; Deidda E; De Stefano E; Dianin F; Raviola C; Silvi C; Marseglia GL; Licari A
Acta Biomed; 2022 Jun; 93(S3):e2022053. PubMed ID: 35666117
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 in patients with severe asthma using biological agents.
Aksu K; Demir Ş; Topel M; Yeşilkaya S; Ateş H; Koca Kalkan İ; Öncül A; Çuhadar Erçelebi D; Türkyılmaz S
Tuberk Toraks; 2021 Sep; 69(3):433-436. PubMed ID: 34581170
[TBL] [Abstract][Full Text] [Related]
11. Asthma in the era of SARS CoV-2 virus.
Bakakos A; Krompa A
J Asthma; 2022 Aug; 59(8):1501-1508. PubMed ID: 34112029
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Asthma: Reflection During the Pandemic.
Liu S; Zhi Y; Ying S
Clin Rev Allergy Immunol; 2020 Aug; 59(1):78-88. PubMed ID: 32468411
[TBL] [Abstract][Full Text] [Related]
13. Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy.
Eger K; Hashimoto S; Braunstahl GJ; Brinke AT; Patberg KW; Beukert A; Smeenk F; van der Sar-van der Brugge S; Weersink EJM; Bel EH
Respir Med; 2021 Feb; 177():106287. PubMed ID: 33388603
[TBL] [Abstract][Full Text] [Related]
14. Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network.
Chiang CY; Ellwood P; Ellwood E; García-Marcos L; Masekela R; Asher I; Badellino H; Sanz AB; Douros K; El Sony A; Diaz CG; Rodríguez MA; Moreno-Salvador A; Pérez-Martini LF; Filho NR; Shpakou A; Sulaimanov S; Tavakol M; Valverde-Molina J; Yousef AA; Pearce N;
Pediatr Allergy Immunol; 2022 Jan; 33(1):e13709. PubMed ID: 34856034
[TBL] [Abstract][Full Text] [Related]
15. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
Kumar K; Hinks TSC; Singanayagam A
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1244-L1247. PubMed ID: 32401670
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in a patient with severe asthma treated with Omalizumab.
Lommatzsch M; Stoll P; Virchow JC
Allergy; 2020 Oct; 75(10):2705-2708. PubMed ID: 32544254
[No Abstract] [Full Text] [Related]
18. Asthma, biologics, corticosteroids, and coronavirus disease 2019.
Akenroye AT; Wood R; Keet C
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):12-13. PubMed ID: 32387535
[No Abstract] [Full Text] [Related]
19. The SARS-CoV-2 pandemic and asthma: What we have learned and what is still unknown.
McPhee C; Yevdokimova K; Rogers L; Kraft M
J Allergy Clin Immunol; 2023 Dec; 152(6):1376-1381. PubMed ID: 37739069
[TBL] [Abstract][Full Text] [Related]
20. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort.
Milger K; Suhling H; Skowasch D; Holtdirk A; Kneidinger N; Behr J; Timmermann H; Schulz C; Schmidt O; Ehmann R; Hamelmann E; Idzko M; Taube C; Lommatzsch M; Buhl R; Korn S
J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2701-2712.e2. PubMed ID: 37301433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
